Description

(7,8-Dimethoxy-2-Oxo-1,2-Dihydro-3H-3-Benzazepin-3-Yl)Acetic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value in the research and development of novel therapeutic agents, particularly within the central nervous system (CNS) and metabolic disorder domains. It is primarily sought by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers for the synthesis of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel benzazepine-based drug candidates.
• Neurological Research: Used in the development of compounds targeting specific receptors within the central nervous system.
• Medicinal Chemistry: Serves as a crucial scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Process Development: Employed in scaling up synthetic routes from laboratory to pilot and commercial production scales.
• Reference Standard: Utilized as an analytical standard for quality control and method validation in API manufacturing.
• Biochemical Research: Applied in studies investigating enzyme inhibition or modulation of specific biological pathways.

Basic Information

Product Name	(7,8-Dimethoxy-2-Oxo-1,2-Dihydro-3H-3-Benzazepin-3-Yl)Acetic Acid
CAS No.	1573547-27-9
Molecular Formula	C₁₅H₁₇NO₆
Molecular Weight	307.30 g/mol
Synonyms	3-Benzazepine-3-acetic acid, 7,8-dimethoxy-1,2-dihydro-2-oxo-; 2-(7,8-Dimethoxy-2-oxo-1,2-dihydro-3H-3-benzazepin-3-yl)acetic acid; (7,8-Dimethoxy-2-oxo-1,2-dihydro-3H-3-benzazepin-3-yl)acetic acid; 3-(Carboxymethyl)-7,8-dimethoxy-1,2-dihydro-3H-3-benzazepin-2-one; CAS 1573547-27-9
EINECS	Contact for details

Quality Control

Our (7,8-Dimethoxy-2-Oxo-1,2-Dihydro-3H-3-Benzazepin-3-Yl)Acetic Acid is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. We provide full traceability and Certificates of Analysis (COA) are available for every shipment, ensuring compliance with the stringent requirements of pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.